Live feed08:00:00·24dPRReleasevia QuantisnowGRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual MeetingByQuantisnow·Wall Street's wire, on your screen.GRAL· GRAIL Inc.Health Care
